Randomised controlled trial to investigate optimal antithrombotic therapy in patients with non-valvular atrial fibrillation undergoing percutaneous coronary intervention: a study protocol of the OPTIMA-AF trial

INTRODUCTION: The optimal antithrombotic strategy for patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI) is uncertain. For patients with non-AF, many trials are now evaluating short 1-month dual antiplatelet therapy. In patients with AF undergoing PCI, in cont...

Descripción completa

Detalles Bibliográficos
Autores principales: Sotomi, Yohei, Kozuma, Ken, Kashiwabara, Kosuke, Higuchi, Yoshiharu, Ando, Kenji, Morino, Yoshihiro, Ako, Junya, Tanabe, Kengo, Muramatsu, Takashi, Nakazawa, Gaku, Hikoso, Shungo, Sakata, Yasushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8671924/
https://www.ncbi.nlm.nih.gov/pubmed/34907043
http://dx.doi.org/10.1136/bmjopen-2020-048354

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8671924/
https://www.ncbi.nlm.nih.gov/pubmed/34907043
http://dx.doi.org/10.1136/bmjopen-2020-048354

Ejemplares similares